PENWEST PHARMACEUTICALS CO. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for PENWEST PHARMACEUTICALS CO.

Sort by

Viewing results 1‒25 of 5973

InterviewBristol-Myers Squibb Co
Bristol Myers Squibb drafts contingency plans for US restrictions on Chinese pharma
...If enacted, the bill will have far-reaching consequences for the US pharmaceutical industry....
April 25, 2024
Drug prices
Copycats take bite out of AbbVie’s best-selling Humira drug
...Along with striking a co-brand deal with CVS to offer Hyrimoz at a discounted price of $1,315 a month, Sandoz has a higher list price version of the biosimilar, priced similarly to Humira at more than $6,000...
April 25, 2024
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Biotech
UK biotech signs $1bn deal to develop liver disease drugs
...It is a similar milestone-based structure to many partnerships in the pharmaceutical industry....
April 22, 2024
News in-depthDementia
Alzheimer’s drug Leqembi falls short of blockbuster status in faltering US rollout
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
April 22, 2024
Eli Lilly & Co
Eli Lilly weight-loss drug found to address sleep apnoea in trial
...the first pharmaceutical treatment for the underlying disease,” said Emmick....
April 17, 2024
Johnson & Johnson Co Inc
Johnson & Johnson buys device maker Shockwave for $13.1bn
US healthcare company is putting cash to work from spinning off its consumer health arm
April 5, 2024
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
LexHelen Thomas
The Lex Newsletter: Living in an Ozempic world Premium content
...The US pharmaceutical company — whose shares are up 130 per cent over the past year and is now a top-10 S&P 500 stock — chose the week of the Oscars to launch an advert called “Big Night”....
March 15, 2024
Eli Lilly & Co
Eli Lilly strikes drug dispensing deal with Amazon
...The push into prescriptions and drug delivery is unusual for a pharmaceutical manufacturer, pitting Eli Lilly against pharmacies such as CVS and Walgreens....
March 13, 2024
John Thornhill
Can 23andMe reinvent itself as a drug discovery company?
...The company has been working with the pharmaceutical giant GSK, focusing on immuno-oncology drugs....
April 4, 2024
Biotech
Gene-editing pioneer calls for big investment in Crispr technology
...therapies based on Crispr gene-editing globally is “unrealistic” and the sector needs heavy investment to make the technology, which could transform treatment of diseases, accessible to all, according to its co-discoverer...
March 21, 2024
Drugs research
Diabetes drug offers hope to Parkinson’s sufferers
...The results will renew attention on the possible effectiveness of lixisenatide, which is made by French pharmaceutical group Sanofi, and other so-called GLP-1 drugs against neurodegenerative conditions....
April 3, 2024
Eli Lilly & Co
US regulator delays decision on Eli Lilly’s Alzheimer’s drug
Breakthrough medicine will now be subject to further review by committee of independent experts
March 8, 2024
The Big Read
The next pandemic is coming. Will we be ready?
...But the proposal has run into opposition from the pharmaceutical industry....
April 4, 2024
News in-depthDrugs research
The race to develop the next generation of weight-loss drugs
...Many biotechs hoping to enter the market will aim for partnerships with larger groups, a well-trodden path in the pharmaceutical industry....
April 1, 2024
Novo Nordisk AS
Novo Nordisk in €1bn deal for RNA-based heart disease therapies
...“We aim to not just alleviate disease symptoms, but to address the root causes of heart failure and restore the normal functioning of the heart,” said Thomas Thum, Cardior’s co-founder....
March 25, 2024
FT Live
Due Diligence Live
Where leaders in investment and finance meet
Tuesday, 8 OctoberLondon, UK
LexEli Lilly & Co
Eli Lilly’s heavyweight status looks set to last Premium content
...Eli Lilly was once considered something of an also-ran in the pharmaceutical industry....
January 16, 2024
LexPharmaceuticals sector
Big Pharma still needs trial success to overcome looming patent panic Premium content
...Pharmaceutical companies must replenish their drugs pipeline before exclusivity rights on top-selling products expire....
February 6, 2024
Drug prices
Rare genetic disease therapy becomes world’s most expensive drug at $4.25mn
...Orchard, a UK-based biotech that was recently bought by Japanese pharmaceutical group Kyowa Kirin, argued that the lack of other treatments for MLD justified the price....
March 20, 2024
News in-depthEli Lilly & Co
Eli Lilly races to boost capacity for rival to Novo Nordisk weight-loss drug
...Eli Lilly is racing to secure the services of outsourcers to boost production of its obesity drug Zepbound, as the US pharmaceutical group rolls out its rival to Danish group Novo Nordisk’s blockbuster appetite...
March 5, 2024
Disease control and prevention
Dispute over genomic databank undermines fight to thwart next pathogen
...Another official said: “What we want to do is give WHO a co-ordinating role but it should not mean that [data] cannot be shared through established systems. It is up to the member states.”...
March 18, 2024
Scientific research
‘Shrinking’ talent pool threatens health progress, warns science chief
...Her comments highlight difficulties in capitalising fully on the rising pace of scientific discoveries, boosted by artificial intelligence, as growing geopolitical tensions hinder international co-operation...
March 3, 2024
Coronavirus
Anti-viral protein found to be important long Covid indicator
...“The presence of interferon-γ could be used to diagnose long Covid in some patients,” said Benjamin Krishna, co-author of the paper and a Cambridge university researcher....
February 21, 2024
Trade Secrets
Biden tries a White House reset on climate and trade Premium content
...US and European pharmaceutical manufacturers are concerned about supply shortages because a Chinese anti-espionage law is deterring them from sending inspectors to certify Chinese production facilities....
April 22, 2024
European companies
Activist investor Jeff Ubben to join Bayer’s supervisory board
...A co-founder of activist fund ValueAct, Ubben said last year that his three-year-old Inclusive Capital was being wound down. He is also on the board of US oil major ExxonMobil....
February 29, 2024
Due Diligence
KKR dragged into another Bill Ackman drama Premium content
...His efforts included a conversation with an unnamed “board member I knew at BI” and approaches to KKR co-founder Henry Kravis, its co-CEO Joseph Bae and Axel Springer’s Döpfner....
January 11, 2024

Previous pagePage 1 of 239Next page